USA Pharma News | Healthcare News 2/4

top of page

iPharmaCenter

News | Blogs | Healthcare | Consulting

Contact: info@ipharmacenter.com

Home
Pharma
Healthcare News
Healthcare Policies
Disease News
Conferences
Others
- COVID-19
- Contact

Search

Biogen initiated Phase 4 trial to determine the efficacy of Spinraza in Zolgensma treated patients

ipharmaservices

Jan 12, 2021

0

REGENERON'S INMAZEB FIRST PRODUCT TO RECEIVE FDA APPROVAL FOR TREATING EBOLA VIRUS

REGENERON'S INMAZEB FIRST PRODUCT TO RECEIVE FDA APPROVAL FOR TREATING EBOLA VIRUS

REGENERON'S INMAZEB FIRST PRODUCT TO RECEIVE FDA APPROVAL FOR TREATING EBOLA VIRUS

ipharmaservices

Oct 18, 2020

0

FDA approved GSK’s Nucala for Hypereosinophilic Syndrome

FDA approved GSK’s Nucala for Hypereosinophilic Syndrome

FDA approved GSK’s Nucala for Hypereosinophilic Syndrome

ipharmaservices

Sep 26, 2020

0

J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

ipharmaservices

Sep 26, 2020

0

Pfizer received the approval of Xalkori for ALK-positive anaplastic large cell lymphoma

Pfizer received the approval of Xalkori for ALK-positive anaplastic large cell lymphoma

Pfizer received the approval of Xalkori for ALK-positive anaplastic large cell lymphoma

ipharmaservices

Sep 24, 2020

0

FDA approved Trelegy Ellipta for asthma, GSK’s triple therapy is now available for asthma and COPD

FDA approved Trelegy Ellipta for asthma, GSK’s triple therapy is now available for asthma and COPD

FDA approved Trelegy Ellipta for asthma, GSK’s triple therapy is now available for asthma and COPD

ipharmaservices

Sep 10, 2020

0

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

ipharmaservices

Sep 9, 2020

0

FDA extended emergency use authorization of Veklury to all hospitalized patients

FDA extended emergency use authorization of Veklury to all hospitalized patients

FDA extended emergency use authorization of Veklury to all hospitalized patients

ipharmaservices

Aug 30, 2020

0

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

ipharmaservices

Aug 27, 2020

0

FDA issued Emergency Use Authorization of Convalescent Plasma for COVID-19 treatment

FDA issued Emergency Use Authorization of Convalescent Plasma for COVID-19 treatment

FDA issued Emergency Use Authorization of Convalescent Plasma for COVID-19 treatment

ipharmaservices

Aug 25, 2020

0

Johnson and Johnson acquired Momenta Pharmaceuticals, aims to strength immunology profile

ipharmaservices

Aug 23, 2020

0

Amgen’s Kyprolis and Janssen’s Darzalex combination approved by the US FDA for multiple myeloma

Amgen’s Kyprolis and Janssen’s Darzalex combination approved by the US FDA for multiple myeloma

Amgen’s Kyprolis and Janssen’s Darzalex combination approved by the US FDA for multiple myeloma

ipharmaservices

Aug 22, 2020

0

Novartis Kesimpta approved for relapsing multiple sclerosis in the US

Novartis Kesimpta approved for relapsing multiple sclerosis in the US

Novartis Kesimpta approved for relapsing multiple sclerosis in the US

ipharmaservices

Aug 21, 2020

0

FDA says no to Gilead’s most anticipated product filgotinib

FDA says no to Gilead’s most anticipated product filgotinib

FDA says no to Gilead’s most anticipated product filgotinib

ipharmaservices

Aug 19, 2020

0

Genentech’s Enspryng approved for Neuromyelitis Optica Spectrum Disorder in the US

Genentech’s Enspryng approved for Neuromyelitis Optica Spectrum Disorder in the US

Genentech’s Enspryng approved for Neuromyelitis Optica Spectrum Disorder in the US

ipharmaservices

Aug 15, 2020

0

Gilead submitted NDA for Veklury to treat COVID-19 in the US

ipharmaservices

Aug 13, 2020

0

FDA approved Genentech’s Evrysdi for Spinal Muscular Atrophy

ipharmaservices

Aug 8, 2020

0

NOVARTIS COSENTYX APPROVED IN EUROPE FOR PAEDIATRIC PSORIASIS

ipharmaservices

Aug 8, 2020

0

GSK’s first anti-BCMA therapy Blenrep was approved in the US

ipharmaservices

Aug 6, 2020

0

Gilead’s CAR-T cell therapy approved for Relapsed or Refractory Mantle Cell Lymphoma

ipharmaservices

Jul 25, 2020

0

For sponsored articles, link insertions, and advertisements, please write to info@ipharmacenter.com

Find the latest pharma and healthcare news on Telegram now. Simply scan the QR code.

Rephrase with Ginger (Cmd+⌥+E)

iPharmaCenter Telegran_edited.jpg

bottom of page